The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Space & Other Races

Space & Other Races

October 19, 2020 • By Philip Seo, MD, MHS

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Orpheus FX / shutterstock.com

Orpheus FX / shutterstock.com

On April 5, 1950, a small group of scientists met in Silver Spring, Md., to talk about geophysics.

You Might Also Like
  • ACR Convergence 2020: Progress Toward COVID-19 Vaccines
  • FDA Authorizes New Long-Acting, Monoclonal Antibodies for Pre-exposure Prevention of COVID-19 in Certain Individuals
  • Regeneron Plans Early Summer Trials for New Antibodies Against Coronavirus
Explore This Issue
October 2020
Also By This Author
  • Ignorant of Ignorance: Medical Education & the Dunning-Kruger Effect

I know this is not the most riveting way to start, but if you stick with me, I promise the story will get much more interesting.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

This group of scientists met to discuss all that was still not understood about the Earth. Together, they realized technology had finally reached the point at which important questions regarding planetary sciences could be tackled.

This meeting led to the International Geophysical Year, a multi-national scientific collaboration that would start on July 1, 1957, to coincide with peak sunspot activity, so scientists could examine the impact of solar activity on the Earth.1

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

I know, I know. Stick with me.

The International Council of Scientific Unions spent seven years planning experiments that would be conducted by 67 countries in more than 4,000 research stations worldwide. The careful planning was warranted because the International Geophysical Year was intended to bring the Cold War to an end.

The years following the end of World War II were characterized by a lack of international scientific exchange, particularly between the U.S. and the Soviet Union. The International Geophysical Year was meant to break the ice and usher in a new era of international collaboration.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

And then the politicians got involved.

In 1955, the U.S. had announced its intent to launch an artificial satellite, ostensibly to celebrate the International Geophysical Year. Not to be outdone, four days later, the Soviet Union announced that it, too, would launch an artificial satellite, also to honor the multi-national scientific collaboration. Unlike the U.S., however, the Soviet Union actually did it.

On Oct. 4, 1957, the Soviet Union launched Sputnik 1, the first man-made satellite to orbit the Earth. Four months later, the U.S. achieved the same landmark, but it was undeniable: the Soviet Union got there first.2

Don’t look now, but Sputnik has beaten us again.

On Aug. 11, 2020, President Vladimir Putin of Russia introduced the world to Sputnik V—not a satellite, but an adenovirus-based vaccine he proclaimed was the first effective defense against SARS-CoV-2. The Russian Health Ministry announced plans to start vaccinating health workers and teachers, followed by the general population, this fall. Millions of doses of the vaccine are being prepared, many of which have already been sold to other nations.3 Meanwhile, the closest competitors are still in clinical trials. What do we know about this vaccine, and more importantly, how did the Russians reach the finish line first?

Pages: 1 2 3 4 5 | Single Page

Filed Under: Drug Updates, Opinion, Rheuminations, Safety Tagged With: COVID-19, vaccinesIssue: October 2020

You Might Also Like:
  • ACR Convergence 2020: Progress Toward COVID-19 Vaccines
  • FDA Authorizes New Long-Acting, Monoclonal Antibodies for Pre-exposure Prevention of COVID-19 in Certain Individuals
  • Regeneron Plans Early Summer Trials for New Antibodies Against Coronavirus
  • CDC Advisers Consider Boosters for Immune-Compromised Americans

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)